CytomX Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -4.92%
- Market cap
- $442.55M
- 218M shares
- Filings
- 801
Q3 2026−44.8% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−66.7% FY25 yoy
- $442.55M
- —
- 31.5×
- 1.6×
- -11.52%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $76,201,000 | reported | |
| FY 2024 | 2024-12-31 | $138,103,000 | reported | |
| FY 2023 | 2023-12-31 | $101,214,000 | reported | |
| FY 2022 | 2022-12-31 | $53,163,000 | reported | |
| FY 2021 | 2021-12-31 | $37,312,000 revised | reported | |
| FY 2020 | 2020-12-31 | $68,427,000 revised | reported | |
| FY 2019 | 2019-12-31 | $26,902,000 revised | reported | |
| FY 2018 | 2018-12-31 | $59,502,000 | reported | |
| FY 2017 | 2017-12-31 | $71,623,000 | reported | |
| FY 2016 | 2016-12-31 | $12,845,000 revised | reported | |
| FY 2015 | 2015-12-31 | $7,712,000 | reported | |
| FY 2014 | 2014-12-31 | $5,077,000 | reported |
Pharmaceutical preparations
CytomX Therapeutics, Inc. is the 111th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ARCTArcturus Therapeutics Holdings Inc.$82.0M46.1%80.2%$298.7MADCTADC Therapeutics SA$81.4M14.9%175.3%$178.8METONEton Pharmaceuticals, Inc.$80.0M104.9%5.8%$1.5B
CTMXCytomX Therapeutics, Inc. (this company)$76.2M44.8%22.8%$442.5M
ABCLAbCellera Biologics Inc.$75.1M160.6%194.9%$3.8BBCYCBicycle Therapeutics PLC$72.6M105.8%301.7%$241.1MASMBAssembly Biosciences, Inc.$72.3M153.5%8.5%$431.6MVRDNViridian Therapeutics, Inc.$70.8M23,359.9%483.6%$3.5BRMTIRockwell Medical, Inc.$69.3M31.8%7.7%$29.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
CytomX Therapeutics, Inc. · CIK 1501989 · Engraved from SEC EDGAR